Below are the most recent publications written about "Lung Transplantation" by people in Profiles.
-
Clancy MJ, Adler J, Tevald MA, Zaleski D, Fluehr L, Wamsley C, Bermudez CA, Crespo MM, Balar P, Oyster ML, Courtwright AM, Diamond JM. Rehabilitation Characteristics and Outcomes for Lung Transplantation for COVID-19: A Case Series. Phys Ther. 2023 05 04; 103(5).
-
Velleca A, Shullo MA, Dhital K, Azeka E, Colvin M, DePasquale E, Farrero M, Garc?a-Guereta L, Jamero G, Khush K, Lavee J, Pouch S, Patel J, Michaud CJ, Shullo MA, Schubert S, Angelini A, Carlos L, Mirabet S, Patel J, Pham M, Urschel S, Kim KH, Miyamoto S, Chih S, Daly K, Grossi P, Jennings DL, Kim IC, Lim HS, Miller T, Potena L, Velleca A, Eisen H, Bellumkonda L, Danziger-Isakov L, Dobbels F, Harkess M, Kim D, Lyster H, Peled Y, Reinhardt Z. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2023 May; 42(5):e1-e141.
-
Bazemore K, Permpalung N, Mathew J, Lemma M, Haile B, Avery R, Kong H, Jang MK, Andargie T, Gopinath S, Nathan SD, Aryal S, Orens J, Valantine H, Agbor-Enoh S, Shah P. Elevated cell-free DNA in respiratory viral infection and associated lung allograft dysfunction. Am J Transplant. 2022 11; 22(11):2560-2570.
-
Todd JL, Neely ML, Overton R, Mulder H, Roman J, Lasky JA, de Andrade JA, Gulati M, Huang H, Leonard TB, Hesslinger C, Noth I, Belperio JA, Flaherty KR, Palmer SM. Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort. Lung. 2022 02; 200(1):11-18.
-
Permpalung N, Sait AS, Bazemore K, Avery RK, Mathew J, Shah PD. Human Metapneumovirus and Parainfluenza Virus Infections in Lung Transplant Recipients: The Effects on Lung Allograft and Clinical Outcomes. Transplantation. 2021 12 01; 105(12):2625-2631.
-
Permpalung N, Bazemore K, Chiang TP, Mathew J, Barker L, Nematollahi S, Cochran W, Sait AS, Avery RK, Shah PD. Impact of COVID-19 on Lung Allograft and Clinical Outcomes in Lung Transplant Recipients: A Case-control Study. Transplantation. 2021 09 01; 105(9):2072-2079.
-
Bazemore K, Rohly M, Permpalung N, Yu K, Timofte I, Brown AW, Orens J, Iacono A, Nathan SD, Avery RK, Valantine H, Agbor-Enoh S, Shah PD. Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury. J Heart Lung Transplant. 2021 11; 40(11):1454-1462.
-
Courtwright AM, Zaleski D, Tevald M, Adler J, Singer JP, Cantu EE, A Bermudez C, Diamond JM. Discharge frailty following lung transplantation. Clin Transplant. 2019 10; 33(10):e13694.
-
Krebs R, Morita Y. Inhaled Pulmonary Vasodilators and Thoracic Organ Transplantation: Does Evidence Support Its Use and Cost Benefit? Semin Cardiothorac Vasc Anesth. 2020 Mar; 24(1):67-73.
-
Fallis RJ, Jablonski L, Moss S, Axelrod P, Clauss H. Infectious complications of bronchial stenosis in lung transplant recipients. Transpl Infect Dis. 2019 Aug; 21(4):e13100.